ID

42533

Description

Study ID: 105874 Clinical Study ID: 105874 Study Title: Bridging Safety & Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00307021 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 Trade Name: N/A Study Indication: Malaria ODM derived from https://clinicaltrials.gov/ct2/show/NCT00307021. A Phase II randomized, double-blind bridging study of the safety and immunogenicity of GlaxoSmithKline Plasmodium falciparum malaria vaccine RTS,S/AS01E (0.5 mL dose) to RTS,S/AS02D (0.5 mL dose) administered IM according to a 0, 1, 2- month vaccination schedule in children aged 18 months to 4 years living in Gabon. Clinical Visits: This study has a total of 7 visits. Visit 1 = Screening, Visits 2-6 are during the double-blind phase (Month 0-3) and Visit 7 is during the single-blind phase (Month 4-14). Vaccine administration takes place during visits 2, 4, and 5 (Visit 2 = Dose 1; Visit 4 = Dose 2; Visit 5 = Dose 3). Field-worker Visits: During the double-blind phase, clinical visits are accompanied by daily field-worker visits subsequent to each vaccine administration visit. Additional field-worker visits also take place during months 4 to 13 of the single-blind phase. Randomisation / Treatment Allocation takes place at visit 2 prior to the first vaccination. The subsequent record treatment number should documented at visit 2. Information on the subject's demographics, body weight, and HBV immunization status (incl. vaccination dates) should also be recorded at clinical visit 2. Please note that informed consent has to be obtained prior to any study procedure.

Lien

https://clinicaltrials.gov/ct2/show/NCT00307021

Mots-clés

Versions (1)
  1. 24/08/2021 24/08/2021 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

24 août 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Safety & Immunogenicity of two GSK Biologicals' Candidate Malaria Vaccines in young children, NCT00307021

Anglais

Demographics, Randomisation, Weight, and HBV Immunization Status

1 Formulaires  
Administrative Documentation
Description

Administrative Documentation

Alias
UMLS CUI-1
C1320722
Subject number
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Date of visit
Description

Date of visit

Type de données

date

Alias
UMLS CUI [1]
C1320303
Demographics
Description

Demographics

Alias
UMLS CUI-1
C0011298
Date of birth
Description

Date of birth

Type de données

date

Alias
UMLS CUI [1]
C0421451
Gender
Description

Gender

Type de données

text

Alias
UMLS CUI [1]
C0079399
Randomisation / Treatment allocation
Description

Randomisation / Treatment allocation

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C1522541
Record treatment number
Description

Treatment number

Type de données

integer

Alias
UMLS CUI [1,1]
C1522541
UMLS CUI [1,2]
C0600091
Body weight
Description

Body weight

Alias
UMLS CUI-1
C0005910
Body weight
Description

Body weight

Type de données

float

Unités de mesure
  • kg
Alias
UMLS CUI [1]
C0005910
kg
HBV immunization status
Description

HBV immunization status

Alias
UMLS CUI-1
C0552506
UMLS CUI-2
C0019163
Was Hepatitis B vaccine administered?
Description

If Yes, please provide the dates of the first, second, and third vaccination in the items below.

Type de données

boolean

Alias
UMLS CUI [1,1]
C2240392
UMLS CUI [1,2]
C2368628
If Yes, date of 1st vaccination
Description

Date in time hepatitis B vaccine administration (1st)

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205435
If Yes, date of 2nd vaccination
Description

Date in time hepatitis B vaccine administration (2nd)

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205436
If Yes, date of 3rd vaccination
Description

Date in time hepatitis B vaccine administration (3rd)

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205437
Retour au début de la page

Similar models

Demographics, Randomisation, Weight, and HBV Immunization Status

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Documentation
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Date of visit
Item
Date of visit
date
C1320303 (UMLS CUI [1])
Item Group
Demographics
C0011298 (UMLS CUI-1)
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (M)
CL Item
Female (F)
Item Group
Randomisation / Treatment allocation
C0034656 (UMLS CUI-1)
C1522541 (UMLS CUI-2)
Treatment number
Item
Record treatment number
integer
C1522541 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Body weight
C0005910 (UMLS CUI-1)
Body weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Item Group
HBV immunization status
C0552506 (UMLS CUI-1)
C0019163 (UMLS CUI-2)
Hepatitis B vaccine administered
Item
Was Hepatitis B vaccine administered?
boolean
C2240392 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
Date in time hepatitis B vaccine administration (1st)
Item
If Yes, date of 1st vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
Date in time hepatitis B vaccine administration (2nd)
Item
If Yes, date of 2nd vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
Date in time hepatitis B vaccine administration (3rd)
Item
If Yes, date of 3rd vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205437 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial